Prospective Observational Epidemiologic Study of Maraviroc's Safety
Prospective Observational Epidemiologic Study of Maraviroc's Safety
This study will assess if use of maraviroc along with an optimized background regimen of antiretroviral drugs in usual clinical practice is as safe as using only an optimized regimen of antiretroviral drugs.
Treatment experienced, HIV-1 infected patients; 18 years or older; Receive an approved assay for determination of HIV-1 tropism
Alyssa Shon, MD
Name: Alyssa Shon, MD
Phone: 898-4119
Email: alyssash@buffalo.edu